was successfully added to your cart.


Is trial and error treatment allocation a thing of the past?  The last 20 years have seen brain imaging techniques evolved immensely, giving mental health practitioners hope that assessments may soon clearly assign a patient to treatment with the highest likelihood of response.  The field of neurofeedback is well on the way. 

neuroCare Australia’s Dr Trevor Brown contributes to PsychScene Hub with a great article on treatment stratification and personalisation of Neurofeedback using QEEG and neuroCare’s leading assessment methods.

For the full article visit PsychScene Hub.

neuroCare Group

About neuroCare Group

The neuroCare Group is a global brand in neuromodulation, active in research training in medication-free applications of Neurostimulation (TMS, tDCS) and Neurofeedback for mental wellness. neuroCare has three vertically integrated divisions, neuroConn Technology, neuroCademy Training & Supervision and neuroCare Clinics